PubMed:12145192
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 120-123 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T2 | 120-123 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T3 | 481-484 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T4 | 481-484 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T5 | 653-656 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T6 | 653-656 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T7 | 857-860 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T8 | 857-860 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T9 | 962-965 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T10 | 962-965 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T11 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T12 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T13 | 1125-1128 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T14 | 1125-1128 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T15 | 1336-1339 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T16 | 1336-1339 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T17 | 1386-1389 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T18 | 1386-1389 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T19 | 1632-1635 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T20 | 1632-1635 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 120-123 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T3 | 481-484 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T5 | 653-656 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T7 | 857-860 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T9 | 962-965 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T11 | 1029-1032 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T13 | 1125-1128 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T15 | 1336-1339 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T17 | 1386-1389 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
T19 | 1632-1635 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
TextSentencer_T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
TextSentencer_T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
TextSentencer_T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
TextSentencer_T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
TextSentencer_T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
TextSentencer_T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
TextSentencer_T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
TextSentencer_T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 120-123 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T2 | 120-123 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T3 | 481-484 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T4 | 481-484 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T5 | 653-656 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T6 | 653-656 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T7 | 857-860 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T8 | 857-860 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T9 | 962-965 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T10 | 962-965 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T11 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T12 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T13 | 1125-1128 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T14 | 1125-1128 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T15 | 1336-1339 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T16 | 1336-1339 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T17 | 1386-1389 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T18 | 1386-1389 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T19 | 1632-1635 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T20 | 1632-1635 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 45-53 | FMAID:86471 | denotes | and cell |
_T2 | 45-53 | FMAID:200932 | denotes | and cell |
_T3 | 108-119 | FMAID:82816 | denotes | ganglioside |
_T4 | 108-119 | FMAID:196811 | denotes | ganglioside |
_T5 | 133-145 | FMAID:196811 | denotes | Gangliosides |
_T6 | 133-145 | FMAID:82816 | denotes | Gangliosides |
_T7 | 296-301 | FMAID:68646 | denotes | cells |
_T8 | 296-301 | FMAID:169002 | denotes | cells |
_T9 | 303-314 | FMAID:196811 | denotes | ganglosides |
_T10 | 303-314 | FMAID:82816 | denotes | ganglosides |
_T11 | 469-480 | FMAID:82816 | denotes | ganglioside |
_T12 | 469-480 | FMAID:196811 | denotes | ganglioside |
_T13 | 537-544 | FMAID:93687 | denotes | ovarial |
_T14 | 537-544 | FMAID:7209 | denotes | ovarial |
_T15 | 571-576 | FMAID:169002 | denotes | cells |
_T16 | 571-576 | FMAID:68646 | denotes | cells |
_T17 | 577-585 | FMAID:86471 | denotes | and cell |
_T18 | 577-585 | FMAID:200932 | denotes | and cell |
_T19 | 631-636 | FMAID:68646 | denotes | cells |
_T20 | 631-636 | FMAID:169002 | denotes | cells |
_T21 | 779-787 | FMAID:82768 | denotes | tyrosine |
_T22 | 779-787 | FMAID:196757 | denotes | tyrosine |
_T23 | 841-847 | FMAID:165145 | denotes | microM |
_T24 | 928-936 | FMAID:84785 | denotes | In cells |
_T25 | 928-936 | FMAID:199054 | denotes | In cells |
_T26 | 931-936 | FMAID:68646 | denotes | cells |
_T27 | 931-936 | FMAID:169002 | denotes | cells |
_T28 | 1190-1202 | FMAID:212684 | denotes | cell surface |
_T29 | 1190-1202 | FMAID:200942 | denotes | cell surface |
_T30 | 1195-1202 | FMAID:146300 | denotes | surface |
_T31 | 1195-1202 | FMAID:50594 | denotes | surface |
_T32 | 1240-1245 | FMAID:68646 | denotes | cells |
_T33 | 1240-1245 | FMAID:169002 | denotes | cells |
_T34 | 1514-1522 | FMAID:82768 | denotes | tyrosine |
_T35 | 1514-1522 | FMAID:196757 | denotes | tyrosine |
_T36 | 1563-1568 | FMAID:169002 | denotes | cells |
_T37 | 1563-1568 | FMAID:68646 | denotes | cells |
_T38 | 1614-1619 | FMAID:169002 | denotes | cells |
_T39 | 1614-1619 | FMAID:68646 | denotes | cells |
_T40 | 1614-1628 | FMAID:226227 | denotes | cells compared |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-17 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T2 | 513-516 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T3 | 756-759 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T4 | 1072-1075 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T5 | 1179-1182 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T6 | 1213-1216 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T7 | 1447-1450 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T8 | 1500-1503 | http://www.uniprot.org/uniprot/P01133 | denotes | EGF |
T9 | 488-511 | http://www.uniprot.org/uniprot/P01133 | denotes | epidermal growth factor |
T10 | 71-74 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T11 | 672-675 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T12 | 820-823 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T13 | 1130-1133 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T14 | 1280-1283 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T15 | 1405-1408 | http://www.uniprot.org/uniprot/Q9NNZ5 | denotes | HK1 |
T16 | 183-205 | http://www.uniprot.org/uniprot/Q9NZT4 | denotes | growth factor receptor |
T17 | 183-205 | http://www.uniprot.org/uniprot/Q9UIH8 | denotes | growth factor receptor |
T18 | 183-205 | http://www.uniprot.org/uniprot/Q9GZX1 | denotes | growth factor receptor |
T19 | 488-511 | http://www.uniprot.org/uniprot/Q9GZX1 | denotes | epidermal growth factor |
T20 | 183-205 | http://www.uniprot.org/uniprot/P08581 | denotes | growth factor receptor |
T21 | 1190-1211 | http://www.uniprot.org/uniprot/Q9UKJ1 | denotes | cell surface receptor |
T22 | 1190-1211 | http://www.uniprot.org/uniprot/Q9UKJ0 | denotes | cell surface receptor |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-17 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T2 | 513-516 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T3 | 756-759 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T4 | 1072-1075 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T5 | 1179-1182 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T6 | 1213-1216 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T7 | 1447-1450 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T8 | 1500-1503 | http://www.uniprot.org/uniprot/P01132 | denotes | EGF |
T9 | 488-511 | http://www.uniprot.org/uniprot/P01132 | denotes | epidermal growth factor |
T10 | 71-74 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
T11 | 672-675 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
T12 | 820-823 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
T13 | 1130-1133 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
T14 | 1280-1283 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
T15 | 1405-1408 | http://www.uniprot.org/uniprot/Q99N14 | denotes | HK1 |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 230-247 | http://purl.bioontology.org/ontology/STY/T043 | denotes | cellular function |
T2 | 296-301 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T3 | 556-565 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
T4 | 571-576 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T5 | 618-627 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
T6 | 631-636 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T7 | 931-936 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T8 | 1240-1245 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T9 | 1563-1568 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T10 | 1614-1619 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 18-44 | http://purl.obolibrary.org/obo/GO_0048260 | denotes | mediated receptor activity |
T2 | 27-53 | http://purl.obolibrary.org/obo/GO_0032393 | denotes | receptor activity and cell |
T3 | 27-53 | http://purl.obolibrary.org/obo/GO_0032394 | denotes | receptor activity and cell |
T4 | 27-53 | http://purl.obolibrary.org/obo/GO_0032395 | denotes | receptor activity and cell |
T5 | 36-53 | http://purl.obolibrary.org/obo/GO_0001775 | denotes | activity and cell |
T6 | 36-67 | http://purl.obolibrary.org/obo/GO_0030890 | denotes | activity and cell proliferation |
T7 | 36-67 | http://purl.obolibrary.org/obo/GO_0050679 | denotes | activity and cell proliferation |
T8 | 36-67 | http://purl.obolibrary.org/obo/GO_0050798 | denotes | activity and cell proliferation |
T9 | 36-67 | http://purl.obolibrary.org/obo/GO_0070668 | denotes | activity and cell proliferation |
T10 | 36-67 | http://purl.obolibrary.org/obo/GO_1904075 | denotes | activity and cell proliferation |
T11 | 36-67 | http://purl.obolibrary.org/obo/GO_1904899 | denotes | activity and cell proliferation |
T12 | 36-67 | http://purl.obolibrary.org/obo/GO_0008284 | denotes | activity and cell proliferation |
T13 | 36-67 | http://purl.obolibrary.org/obo/GO_1904197 | denotes | activity and cell proliferation |
T14 | 49-67 | http://purl.obolibrary.org/obo/GO_0008283 | denotes | cell proliferation |
T15 | 71-74 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T16 | 672-675 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T17 | 820-823 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T18 | 1130-1133 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T19 | 1280-1283 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T20 | 1405-1408 | http://purl.obolibrary.org/obo/GO_0004673 | denotes | HK1 |
T21 | 183-189 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T22 | 498-504 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T23 | 586-592 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T24 | 1227-1233 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T25 | 1601-1607 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T26 | 230-238 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
T27 | 518-527 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T28 | 581-592 | http://purl.obolibrary.org/obo/GO_0016049 | denotes | cell growth |
T29 | 788-803 | http://purl.obolibrary.org/obo/GO_0016310 | denotes | phosphorylation |
T30 | 1095-1110 | http://purl.obolibrary.org/obo/GO_0016310 | denotes | phosphorylation |
T31 | 1523-1538 | http://purl.obolibrary.org/obo/GO_0016310 | denotes | phosphorylation |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-17 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T2 | 513-516 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T3 | 756-759 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T4 | 1072-1075 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T5 | 1179-1182 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T6 | 1213-1216 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T7 | 1447-1450 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T8 | 1500-1503 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T9 | 1587-1590 | http://purl.obolibrary.org/obo/GO_0005154 | denotes | EGF |
T10 | 27-53 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | receptor activity and cell |
T11 | 27-53 | http://purl.obolibrary.org/obo/GO_0050839 | denotes | receptor activity and cell |
T12 | 183-205 | http://purl.obolibrary.org/obo/GO_0070851 | denotes | growth factor receptor |
T13 | 1161-1168 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T14 | 1161-1168 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T15 | 1161-1168 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T16 | 1161-1168 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 49-53 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T2 | 581-585 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T3 | 296-301 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T4 | 571-576 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T5 | 631-636 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T6 | 931-936 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T7 | 1240-1245 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T8 | 1563-1568 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T9 | 1614-1619 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T10 | 1190-1202 | http://purl.obolibrary.org/obo/GO_0009986 | denotes | cell surface |
EDAM-topics
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 407-412 | http://edamontology.org/topic_3678 | denotes | study |
T2 | 531-536 | http://edamontology.org/topic_2815 | denotes | human |
T3 | 596-601 | http://edamontology.org/topic_2815 | denotes | human |
EDAM-DFO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 266-268 | http://edamontology.org/format_1997 | denotes | pH |
T2 | 912-926 | http://edamontology.org/data_2140 | denotes | concentrations |
T3 | 952-954 | http://edamontology.org/format_1997 | denotes | pH |
T4 | 1309-1323 | http://edamontology.org/data_2140 | denotes | concentrations |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 290-295 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T2 | 545-565 | Disease | denotes | epidermoid carcinoma | http://purl.obolibrary.org/obo/MONDO_0005096 |
T3 | 607-627 | Disease | denotes | epidermoid carcinoma | http://purl.obolibrary.org/obo/MONDO_0005096 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 290-295 | Phenotype | denotes | tumor | HP:0002664 |
T2 | 556-565 | Phenotype | denotes | carcinoma | HP:0030731 |
T3 | 618-627 | Phenotype | denotes | carcinoma | HP:0030731 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 120-123 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T2 | 481-484 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T3 | 653-656 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T4 | 857-860 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T5 | 962-965 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T6 | 1029-1032 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T7 | 1125-1128 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T8 | 1336-1339 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T9 | 1386-1389 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T10 | 1632-1635 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 290-295 | Phenotype | denotes | tumor | HP:0002664 |
T2 | 556-565 | Phenotype | denotes | carcinoma | HP:0030731 |
T3 | 618-627 | Phenotype | denotes | carcinoma | HP:0030731 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 290-295 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T2 | 545-565 | Disease | denotes | epidermoid carcinoma | http://purl.obolibrary.org/obo/MONDO_0005096 |
T3 | 607-627 | Disease | denotes | epidermoid carcinoma | http://purl.obolibrary.org/obo/MONDO_0005096 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 531-536 | OrganismTaxon | denotes | human | 9606 |
T2 | 596-601 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 290-301 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 488-504 | Body_part | denotes | epidermal growth | http://purl.obolibrary.org/obo/UBERON_0000021 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
TextSentencer_T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
TextSentencer_T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
TextSentencer_T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
TextSentencer_T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
TextSentencer_T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
TextSentencer_T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
TextSentencer_T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
TextSentencer_T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-132 | Sentence | denotes | Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. |
T2 | 133-248 | Sentence | denotes | Gangliosides have been described as modulators of growth factor receptor activity and subsequent cellular function. |
T3 | 249-391 | Sentence | denotes | Due to the lower-pH environment found in tumor cells, ganglosides are thought to be formed (at least to some extent) into their lactone forms. |
T4 | 392-732 | Sentence | denotes | The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. |
T5 | 733-927 | Sentence | denotes | Specific inhibition of EGF-dependent receptor tyrosine phosphorylation was observed by HK1-ceramide 2 at 25 microM, whereas GM3 showed a comparable inhibition at eightfold higher concentrations. |
T6 | 928-1111 | Sentence | denotes | In cells exposed to low pH, where GM3 is thought to form its lactone to a higher extent, addition of GM3 showed no further inhibitory effect on EGF-dependent receptor phosphorylation. |
T7 | 1112-1212 | Sentence | denotes | Similarly to GM3, HK1-ceramide 2 does not affect binding of (125)I-EGF to the cell surface receptor. |
T8 | 1213-1340 | Sentence | denotes | EGF-dependent growth of KB cells was also found to be inhibited by HK1-ceramide 2 at much lower concentrations compared to GM3. |
T9 | 1341-1636 | Sentence | denotes | In conclusion, our results indicate that the GM3 lactone analog HK1-ceramide 2 is a specific inhibitor of EGF receptor function and is more potent in reducing EGF-dependent tyrosine phosphorylation of the receptor in A431 cells and in inhibiting EGF-dependent growth of KB cells compared to GM3. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 120-123 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T2 | 481-484 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T3 | 653-656 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T4 | 857-860 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T5 | 962-965 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T6 | 1029-1032 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T7 | 1125-1128 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T8 | 1336-1339 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T9 | 1386-1389 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
T10 | 1632-1635 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 531-536 | OrganismTaxon | denotes | human | 9606 |
T2 | 596-601 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 488-504 | Body_part | denotes | epidermal growth | http://purl.obolibrary.org/obo/UBERON_0000021 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 290-301 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |